Genecare, Jupiter Chain team up for genetic profiling platform

Image courtesy of Jupiter Chain

Genetics testing firm Genecare has partnered with Jupiter Chain to release a secure online genetic profiling platform.

The ASEAN-based company makes use of whole genome sequencing to detect a client’s genetic variance and susceptibility to diseases or abnormalities.

Once ready, the results will be uploaded onto Genecare’s app called NexTx. It contains medical professionals and lifestyle service providers who offer precise and targeted advice based on the client’s genetic profiling for preventive healthcare consultation.

Medical experts will offer customised medical recommendations while lifestyle service providers such as fitness clubs can create tailor-made exercise plans based on the client’s genetic makeup.

The providers will then be able to input their observations and recommendations into the client’s profile.

The NexTx technology reduces time to track down information across different systems. However, as convenient as this may sound, there are widespread concerns about privacy since any form of medical data is highly sensitive.

To address these worries, Genecare is working with Jupiter Chain to enable blockchain technology for NexTx’s ecosystem.

“Without blockchain technology, there is always the risk of data breaches. Leaked personal data, can lead to devastating outcomes, such as manipulated medical records or discriminatory treatment from others due to exposed medical history,” said Lew Hon Kean, CEO of Genecare. “With Jupiter Chain, consumers will have a layer of security protecting their data.” 

Jupiter Chain is a smart, consentable data platform that allows users to maintain data privacy by encrypting their data and requiring consent before other parties can access the necessary information to perform big data analytics.

“With Jupiter Chain, service providers only get the assessment result and will not see the genetic data,” said Ernie Teo, CTO of Jupiter Chain. “This ensures the privacy of users while allowing them to get access to tailored healthcare products and services.”